EQS-Adhoc: Ad hoc: MorphoSys AG Reports Preliminary 2023 Monjuvi U.S. Net Product Sales and Gross Margin, Provides 2024 Financial Guidance and Reduces Financial Liability - adhoc - Börsennachrichten

EQSAdhoc MorphoSys AG Key word Forecast Ad hoc MorphoSys AG Reports Preliminary 2023 Monjuvi US Net Product Sales and Gross Margin Provides 2024 Financial Guidance and Reduces Financial Liability 30J

Related Keywords

Planegg ,Bayern ,Germany , ,Nasdaq ,Product Sales ,Gross Margin ,Reduces Financial ,Morphosy Phase ,Eqsadhoc ,Morphosys ,Forecast ,Reports ,Reliminary ,Monjuvi ,Product ,Sales ,Cross ,Margin ,Rovides ,Financial ,Guidance ,Educes ,Liability ,Etcest ,Disclosure ,Inside ,Information ,Article ,Regul ,